Metrics Contract Services’ parent company, Mayne Pharma, will invest $65 million to significantly expand facilities and equipment at its site in Greenville, N.C. The company’s plans include the greenfield construction of a new state-of-the-art, 126,000-square-foot, large-scale oral-dose commercial manufacturing facility as well as a visitor center and administration building. Renovation to the existing space will significantly increase pharmaceutical development and CTM capacity plus expand our analytical laboratories.
Literature / Brochures
Facility Expansion and Renovation
More Literature / Brochures by Metrics Contract Services
-
Brochures
Analytical Equipment List
Quantity/Type • 90 HPLC systems (Agilent 1100–1200 series, Shimadzu LC-2010 CHT, Waters 2695, and Hitachi 7000); HPIC systems (Dionex ICS-5000 and 2500); UPLC systems (Waters Acquity H-Class, Shimadzu Prominence UFLC) Services include GP…01.29.16
-
Brochures
Analytical and Microbiological Services
The Answers You Need. When You Need Them. Metrics’ experienced scientists offer method development, validation, and stability testing services to meet your challenging analytical needs and timelines in a cGMP compliant facility. The Metrics d…01.29.16
-
Brochures
Manufacturing Equipment List
Blenders Blender: Turbula T2F Blender, V-shell: 1 pt to 2 qt; Patterson-Kelly Blenders (2); V-shell; 1 pt to 16 qt; with Intensifier Bar: GlobePharma Blenders (2); V-shell; 8 qt; Keith Machinery Blender, Cross-flow: 16 qt; Patterson-Kelley Ble…01.29.16
-
Brochures
Potent Products
Metrics’ Potent and Cytotoxic Drug Development Facility. With our state-of-the-art potent and cytotoxic pharmaceutical cGMP suites, Metrics can provide its renowned reliability, flexibility and client services for your potent drug products. O…01.29.16
-
Brochures
Product Development Lab
Metrics is pleased to introduce our new fast-track product development laboratory. The 4,524-square-foot addition provides for manufacturing and laboratory space as well as office and conference room space.…01.29.16
-
Brochures
Specialty Pharmaceutical Technologies
Metrics Contract Services is a contract development and manufacturing organization (CDMO) offering a range of drug product development services from Phase I through Phase III CTM and commercial manufacturing for multiple dosage forms.…01.29.16
More Content From Metrics Contract Services
-
A Case Study of Effect of Binder Type on Dry Granulation
OBJECTIVE The purpose of the present investigation was to compare the impact of roller compaction processing parameters and resulting tableting properties of roller compacted granules of Avicel ® DG (ADG) [Spray Dried-Co-processed Microcrystalli…White Papers / Tech Papers Released on 05.04.2016
-
THE VERSATILITY OF CHARGED AEROSOL DETECTION
Charged Aerosol Detection (CAD) applies to a broad range of HPLC separations and possesses a number of desirable characteristics for detection and quantitation of various compounds including those without UV absorbing chromophores.…White Papers / Tech Papers Released on 04.20.2016
-
Physical Appearance Determination of a Drug Substance Utilizing a Commercially Available Color Guide
OBJECTIVE To develop a robust method to determine the physical color appearance of drug substance X that eliminates the subjective human bias for color selection.…White Papers / Tech Papers Released on 04.06.2016
-
Virtual Pharma Companies: The Future is Now
Virtual pharma companies are growing because the business model works. Experience and flexibility is key for CDMOs to work successfully with them.…White Papers / Tech Papers Released on 03.23.2016
-
A Case Study of Formulating ‘One and Done’ Daily Dosing Involving a Highly Water-Soluble API
The Issue Metrics Contract Services was approached by a client with a commercialized drug product indicated for curative treatment. The client needed a second-generation formulation for a clinical trial studying the drug’s efficacy as a preven…White Papers / Tech Papers Released on 03.09.2016
-
Determination of TFA Levels Using F-NMR
OBJECTIVE Determination of trifluoroacetic acid (TFA) levels in human urine, using 19F Nuclear Magnetic Resonance (NMR).…White Papers / Tech Papers Released on 02.24.2016
-
Metrics Contract Services to Offer ‘Concept to Commercialization’ with Expanded Facility
The parent company of Metrics Contract Services, Mayne Pharma, is investing $65M to significantly expand facilities and equipment at its site in Greenville, N.C. The company’s investment will create new analytical labs and formulation developme…News Releases Released on 02.10.2016
-
Metrics Contract Services Appoints Vice President of Analytical Services
Providing strategic oversight to a team of 100+ chemists, Keith Moore will support Metrics Contract Services with its rapidly growing client base and ever-evolving international quality compliance regulations.…News Releases Released on 02.10.2016
-
Metrics Contract Services Expands Staff with New Senior Formulation Scientist
Michael R. Mascarenas provides clients with quality formulation and process development of early-phase oral dosage forms.…News Releases Released on 02.10.2016
-
Metrics Contract Services Expands Analytical Lab Capabilities with Additional UPLC Equipment
The company’s investment in leading liquid chromatography technologies will provide additional capability in services clients are seeking.…News Releases Released on 02.10.2016
-
A Case Study of Using Common Low Moisture Fillers in the Roller Compacted Tablets
OBJECTIVE The aim of this study was to compare the benefit of using common low moisture grade pharmaceutical excipients: Mannitol, NF (Grades: Pearlitol® 300 DC, Pearlitol® 160c) (Roquette) and/or Microcrystalline Cellulose, NF (Grades: Avic…White Papers / Tech Papers Released on 02.10.2016
-
Using Quality by Design (QbD) for Process Optimization of a Novel Oral Solid Dosage Form
by Joe Cobb, R. Justin Brett, Michael D. Ruff, Anthony Berry, Robert Epps OBJECTIVE To improve robustness of a core tablet for a novel modified release oral solid dosage form using Quality by Design (QbD) principles. General Background As stated in…White Papers / Tech Papers Released on 04.04.2013
